Is GlaxoSmithKline (GSK) about to throw down with Gilead Sciences (GILD) over a new HIV drug? Getty Images RBC Capital Markets analyst Brain Abrahams says that recent patent portfolio activity by Glaxo suggests that the British drug maker may be preparing to initiate a lawsuit claiming that Gilead’s experimental HIV drug bictegravir infringes on its […]